|
|
Scientific Program Last update May 17, 2012 |
|
Wednesday, June 6, 2012
|
|
10:00 - 18:00
|
Registration
|
|
Hall Presidents I & II
|
|
13:30 - 15:30
|
Moderators: Rajan Gupta - John Kurhanewicz - Alex Kirkham
Poster No P1-P19
|
|
Hall Presidents III
|
|
13:30 - 15:30
|
Moderators: Thomas Polascik - Jurgen Futterer - Ed Rampesaud
|
|
Hall Presidents IV
|
|
13:30 - 15:30
|
Moderators: Steven Joniau - Bruce Shingleton - James Meler
Poster No K1-K8
|
|
15:30 - 15:45
|
COFFEE BREAK
|
|
|
|
15:45 - 16:30
|
Lecture
XGEVA (denosumab) and Prostae Cancer: Identifying Bone Metastases and Preventing Skeletal - Related Events
Judd Moul, Durham - USA
Cordialy supported by AMGEN
Not Duke - sponsored nor CME credit source
|
|
16:30 - 18:00
|
Video session: "This is how I do it"
Not Duke - sponsored nor CME credit source
Moderator: Thomas Polascik
(6 video presentation x 12 minutes + 3 minutes discussion)
|
|
18:00 - 18:30
|
Opening Ceremony
|
|
18:30
|
Welcome Reception
|
|
Thursday, June 7, 2012
|
|
|
|
07:30 - 09:45
|
Session 1: Imaging and New Concepts
Moderators: James Meler - Raymond Leveillee - Christoph Klingler
Welcome & renal program overview
Thomas Polascik, Durham - USA
Quantitative Characterization of renal tumors on CT
Mihir Desai, Los Angeles - USA
The Endourology Society Lecture: Role of active surveillance
Jaime Landman, Irvine - USA
Should biopsy of the small renal mass be a standard of care?
Pilar Laguna, Amsterdam - The Netherlands
Fusion ultrasound: the future of image-guided renal therapy?
Bruce Shingleton, Augusta - USA
The EAU Section fo Urological Imaging (ESUI) Lecture:
Monitoring the effect of renal ablation and antiangiogenic with CEUS
Hessel Wijkstra, Amsterdam - The Netherlands
The Society of Urologic Oncology (SUO) Lecture:
Neoadjuvant cancer ablation to enhance active immunotherapy
Arie Belldegrun, Los Angeles - USA
Panel Discussion
|
|
09:45 - 10:15
|
COFFEE BREAK
|
|
10:15 - 12:00
|
Session 2: Technologies: efficacy, morbidity, costs
Moderators: Jaime Landman - Benjamin Lee - David Sopko
Percutaneous and laparoscopic cryoablation: 10 year data
Monish Aron, Los Angeles - USA
Update on utility of renal HIFU
Christoph Klingler, Vienna - Austria
Percutaneous low energy direct current (IRE)
James D. Meler, Houston - USA
Alternative energy sources: What's on the horizon
Raymond Leveillee, Miami - USA
Advances in partial nephrectomy: Zero-ischemia technique
Inderbir Gill, Los Angeles-USA
Round table discussion: Patient selection - AS, ablate, resect?
|
|
12:00 - 13:00
|
Lunch Symposium
Cordialy supported by GALIL MEDICAL
Not Duke - sponsored nor CME credit source
|
|
13:00 - 14:30
|
Session 3: Post treatment surveillance
Moderators: Monish Aron - Michael Marberger - Rendon Nelson
Post ablation enhancement: Definitions, implications, role of biopsy
Charles Kim, Durham - USA
Post ablation surveillance: Managing radiation exposure
Michael Ferrandino, Durham - USA
The EAU Section of Uro-Technology (ESUT) Lecture:
Interpreting EAU and AUA guidelines for the small renal mass
Steven Joniau, Leuven - Belgium
How to start a focal renal program
Benjamin Lee, New Orleans - USA
Panel Discussion
Close of kidney program
Pilar Laguna, Amsterdam - The Netherlands
|
|
14:30 -16:25
|
Session 4: Foundation for Focal Therapy
Moderators: Arnauld Villers - Aaron Katz - Angelo DeMarzo
Welcome
Jean De La Rosette, Amsterdam - The Netherlands
Biological characterization of the Index lesion
Hashim Uddin Ahmed, London - United Kingdom
Nanomedicines for diagnosis and treatment of PCa
Omid Farokhzad, Boston - USA
Role of focal therapy in the treatment armamentarium
Cary Robertson, Durham - USA
Patient Selection
J. Stephen Jones, Cleveland - USA
A rational sampling strategy for focal therapy
Hashim Uddin Ahmed, London - United Kingdom
Panel Discussion
|
|
16:25-16:45
|
Coffee Break
|
|
16:45-18:15
|
Session 5: New Concepts in FT
Moderators: Judd Moul - Peter Pinto - James Donovan
The American College of Cryosurgery (ACC) Lecture:
Hallmarks of cancer and thermal ablative therapies
John Baust, Binghamton - USA
Biomarkers to improve risk assessment
Angelo DeMarzo, Baltimore - USA
Chemoprevention and adjuncts
Daniel George, Durham - USA
Panel Discussion
|
|
Friday, June 8, 2012
|
|
Hall Presidents I & II
|
|
07:30 - 10:00
|
Session 6: Role of Ultrasound in diagnosis and targeting
Moderator: Peter Choyke
Targeted ultrasound bubbles for targeted therapies
Hessel Wijkstra, Amsterdam - The Netherlands
Acoustic Radiation Force Impulse (ARFI) Elasticity imaging of prostate
Kathy Nightingale, Durham - USA
Targeted US-MRI fusion
Peter Pinto, Bethesda - USA
Elastic (non-rigid) MR-US fusion targeted biopsy
Inderbir Gill, Los Angeles - USA
Real time ultrasound monitoring of tissue changes
Michael Marberger, Vienna - Austria
RF spectral analysis of prostate ultrasound
Ernest J. Feleppa, New York - USA
Update on Histoscanning
Ananthakrishnan Sivaraman, Orlando - USA
Real-time TRUS based 3D mapping
Osamu Ukimura, Los Angeles - USA
Panel Discussion
|
|
10:00 - 10:30
|
In Vivo Lecture
Not Duke - sponsored nor CME credit source
|
|
10:30 - 10:45
|
COFFEE BREAK
|
|
10:45-13:15
|
Session 7: Role of MRI
Moderators: John Trachtenberg - John Feller - Daniel Boll
How I use MRI in prostate cancer practice
Peter Choyke, Bethesda - USA
What MRI can see and what it cannot
Arnauld Villers, Lille - France
Image-guided diagnosis and followup
Alex Kirkham, London - United Kingdom
MRI spect
John Kurhanewicz, San Fransisco - USA
What does MRI need to do to become standard of care?
Jurgen Futterer, Nijmegen-The Netherlands
Starting a MRI program in focal therapy
Rajan Gupta, Durham - USA
Endourethral MRI guided ablation with MRI thermometry
Laurence Klotz, Toronto - Canada
Robotic image - guded focal laser therapy
John Trachtenberg, Toronto - Canada
Panel discussion
|
|
13:15 - 14:15
|
Lunch Session
Renal Cryoablation: Freeze it and forget it
Michael Fabrizio, Norfolk - USA
Cordialy supported by HEALTHTRONICS
Not Duke - sponsored nor CME credit source
|
|
14:15 - 16:45
|
Session 8: Targeted therapy
Moderators: Michael Marberger - Thomas Polascik - Jason Donovan
Summary of Consensus Group II report on MRI
Jean de la Rosette, Amsterdam - The Netherlands
MRI-guided biopsy: ready for prime time?
Sadhna Verma, Cincinnati - USA
Transrectal MRI guided laser ablation
John Feller, USA
Focal Cryoablation
J. Stephen Jones, Cleveland - USA
How does Focal compare to whole gland cryotherapy in the salvage setting?
Aaron Katz, New York - USA
Focal Low Energy Direct Current (IRE)
Jaime Wong, Goergia - USA
Focal HIFU update on phase I/II studies
Hashim Uddin Ahmed, London - United Kingdom
Photodynamic therapy (TOOKAD® Soluble VTP). From bench to bedside
Jonathan Coleman, New York - USA
Panel Discussion
|
|
16:45
|
Closing remarks and announcement of the 6th Focal Therapy Symposium
Jean de la Rosette, Amsterdam - The Netherlands
|
|
|
|
Industry Supporters
|
|
Platinum Support
|
|
|
|
Gold Support
|
|
|
|
Silver Support
|
|
|
|
Bronze Support
|
|
 
|
|
|
Print 